{
     "PMID": "24985687",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20150209",
     "LR": "20161125",
     "IS": "1552-5279 (Electronic) 1552-5260 (Linking)",
     "VI": "10",
     "IP": "4",
     "DP": "2014 Jul",
     "TI": "Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease.",
     "PG": "421-9.e3",
     "LID": "10.1016/j.jalz.2013.07.003 [doi] S1552-5260(13)02497-7 [pii]",
     "AB": "BACKGROUND: Regulatory qualification of a biomarker for a defined context of use provides scientifically robust assurances to sponsors and regulators that accelerate appropriate adoption of biomarkers into drug development. METHODS: The Coalition Against Major Diseases submitted a dossier to the Scientific Advice Working Party of the European Medicines Agency requesting a qualification opinion on the use of hippocampal volume as a biomarker for enriching clinical trials in subjects with mild cognitive impairment, incorporating a scientific rationale, a literature review and a de novo analysis of Alzheimer's Disease Neuroimaging Initiative data. RESULTS: The literature review and de novo analysis were consistent with the proposed context of use, and the Committee for Medicinal Products for Human Use released an opinion in November 2011. CONCLUSIONS: We summarize the scientific rationale and the data that supported the first qualification of an imaging biomarker by the European Medicines Agency.",
     "CI": [
          "Copyright (c) 2014 The Alzheimer's Association. All rights reserved."
     ],
     "FAU": [
          "Hill, Derek L G",
          "Schwarz, Adam J",
          "Isaac, Maria",
          "Pani, Luca",
          "Vamvakas, Spiros",
          "Hemmings, Robert",
          "Carrillo, Maria C",
          "Yu, Peng",
          "Sun, Jia",
          "Beckett, Laurel",
          "Boccardi, Marina",
          "Brewer, James",
          "Brumfield, Martha",
          "Cantillon, Marc",
          "Cole, Patricia E",
          "Fox, Nick",
          "Frisoni, Giovanni B",
          "Jack, Clifford",
          "Kelleher, Thomas",
          "Luo, Feng",
          "Novak, Gerald",
          "Maguire, Paul",
          "Meibach, Richard",
          "Patterson, Patricia",
          "Bain, Lisa",
          "Sampaio, Cristina",
          "Raunig, David",
          "Soares, Holly",
          "Suhy, Joyce",
          "Wang, Huanli",
          "Wolz, Robin",
          "Stephenson, Diane"
     ],
     "AU": [
          "Hill DL",
          "Schwarz AJ",
          "Isaac M",
          "Pani L",
          "Vamvakas S",
          "Hemmings R",
          "Carrillo MC",
          "Yu P",
          "Sun J",
          "Beckett L",
          "Boccardi M",
          "Brewer J",
          "Brumfield M",
          "Cantillon M",
          "Cole PE",
          "Fox N",
          "Frisoni GB",
          "Jack C",
          "Kelleher T",
          "Luo F",
          "Novak G",
          "Maguire P",
          "Meibach R",
          "Patterson P",
          "Bain L",
          "Sampaio C",
          "Raunig D",
          "Soares H",
          "Suhy J",
          "Wang H",
          "Wolz R",
          "Stephenson D"
     ],
     "AD": "IXICO Ltd., London, UK. Eli Lilly and Company, Indianapolis, IN, USA. European Medicines Agency, London, UK. European Medicines Agency, London, UK. European Medicines Agency, London, UK. European Medicines Agency, London, UK. Alzheimer's Association, Chicago, IL, USA. Eli Lilly and Company, Indianapolis, IN, USA. Eli Lilly and Company, Indianapolis, IN, USA; The University of Texas School of Public Health, Houston, TX, USA. University of California, Davis, CA, USA. IRCCS Fatebenefratelli, Brescia, Italy. University of California, San Diego, CA, USA. Coalition Against Major Diseases, Critical Path Institute, Tucson, AZ, USA. Wellnessmanagments.com, Livingston, NJ, USA. Eli Lilly and Company, Indianapolis, IN, USA. UCL Institute of Neurology, London, UK. IRCCS Fatebenefratelli, Brescia, Italy. Mayo Clinic, Rochester, MN, USA. Bristol Myers Squibb, Wallingford, CT, USA. Bristol Myers Squibb, Wallingford, CT, USA. Janssen Pharmaceutical Research and Development, Titusville, NJ, USA. Novartis, Basel, Switzerland. Novartis, NJ, USA. AstraZeneca, Wilmington, DE, USA. Independent science writer, Elverson, PA, USA. CHDI Foundation Inc., Princeton, NJ, USA. ICON Medical Imaging, Warrington, PA, USA. Bristol Myers Squibb, Wallingford, CT, USA. SYNARC Inc., Newark, CA, USA. University of California, Davis, CA, USA. IXICO Ltd., London, UK; Department of Computing, Imperial College London, London, UK. Coalition Against Major Diseases, Critical Path Institute, Tucson, AZ, USA. Electronic address: DStephenson@c-path.org.",
     "LA": [
          "eng"
     ],
     "GR": [
          "U01FD003865/FD/FDA HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "United States",
     "TA": "Alzheimers Dement",
     "JT": "Alzheimer's & dementia : the journal of the Alzheimer's Association",
     "JID": "101231978",
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/*diagnosis/*therapy",
          "*Clinical Trials as Topic",
          "Cognitive Dysfunction",
          "Databases, Factual/statistics & numerical data",
          "Disease Progression",
          "Europe",
          "Hippocampus/*pathology",
          "Humans",
          "Neuroimaging",
          "Proportional Hazards Models",
          "ROC Curve"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer's Disease Neuroimaging Initiative",
          "Alzheimer's disease",
          "Hippocampal volume",
          "Mild cognitive impairment"
     ],
     "EDAT": "2014/07/06 06:00",
     "MHDA": "2015/02/11 06:00",
     "CRDT": [
          "2014/07/03 06:00"
     ],
     "PHST": [
          "2013/01/31 00:00 [received]",
          "2013/06/26 00:00 [revised]",
          "2013/07/23 00:00 [accepted]",
          "2014/07/03 06:00 [entrez]",
          "2014/07/06 06:00 [pubmed]",
          "2015/02/11 06:00 [medline]"
     ],
     "AID": [
          "S1552-5260(13)02497-7 [pii]",
          "10.1016/j.jalz.2013.07.003 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Alzheimers Dement. 2014 Jul;10(4):421-9.e3. doi: 10.1016/j.jalz.2013.07.003.",
     "term": "hippocampus"
}